adamantane has been researched along with Nervous System Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali Shah, SJ; Iqbal, J; Mahmood, A | 1 |
| Butterworth, RF | 1 |
| Ametamey, SM; Bieri, D; Herde, AM; Krämer, SD; Mu, L; Schibli, R; Slavik, R; Weber, M | 1 |
| Abughali, N; Abzug, MJ; Bradley, JS; Cloud, GA; Englund, J; Griffin, J; Guzman-Cottrill, J; Jacobs, RF; Jester, P; Kimberlin, DW; Lang, D; Leach, C; Ramilo, O; Robinson, J; Romero, JR; Shalabi, M; Shelton, M; Storch, G; Wade, KC; Whitley, RJ | 1 |
1 review(s) available for adamantane and Nervous System Disorders
| Article | Year |
|---|---|
Potential for the Repurposing of Adamantane Antivirals for COVID-19.
Topics: Adamantane; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Nervous System Diseases | 2021 |
3 other study(ies) available for adamantane and Nervous System Disorders
| Article | Year |
|---|---|
Design and synthesis of adamantane-1-carbonyl thiourea derivatives as potent and selective inhibitors of h-P2X4 and h-P2X7 receptors: An Emerging therapeutic tool for treatment of inflammation and neurological disorders.
Topics: Adamantane; Humans; Inflammation; Nervous System Diseases; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Thiourea | 2022 |
Synthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor.
Topics: Adamantane; Animals; Autoradiography; Carbon Radioisotopes; Disease Models, Animal; Humans; Inflammation; Male; Mice; Molecular Imaging; Molecular Structure; Nervous System Diseases; Positron-Emission Tomography; Quinolones; Rats; Rats, Wistar; Receptor, Cannabinoid, CB2; Tissue Distribution | 2015 |
Safety of oseltamivir compared with the adamantanes in children less than 12 months of age.
Topics: Adamantane; Antiviral Agents; Central Nervous System; Female; Humans; Infant; Infant, Newborn; Influenza, Human; Male; Nervous System Diseases; Oseltamivir; Retrospective Studies; Rimantadine | 2010 |